Proregenerative MicroRNAs to Repair the Damaged Heart.
Camilla Olianti1,2, Mauro Giacca1,2,3
1School of Cardiovascular and Metabolic Medicine & Sciences and British Heart Foundation Centre of Research Excellence, King's College London London, UK.
European Cardiology
|October 20, 2025
Summary
MicroRNAs can stimulate cardiomyocyte proliferation, offering a potential therapeutic strategy for cardiac regeneration after heart attacks. This approach aims to restore heart function by promoting the growth of new heart muscle cells.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Molecular Biology
Background:
- Myocardial infarction (MI) leads to significant cardiomyocyte loss, contributing to heart failure.
- Adults lack natural cardiomyocyte regeneration, unlike neonates and other species.
- Understanding molecular pathways of cardiomyocyte proliferation is crucial.
Purpose of the Study:
- To review microRNAs that induce cardiomyocyte proliferation.
- To highlight the clinical potential of specific microRNAs for cardiac repair.
- To discuss gene targets and regenerative effects of key microRNAs.
Main Methods:
- Review of scientific literature on microRNAs and cardiac regeneration.
- Identification of microRNAs shown to stimulate cardiomyocyte proliferation.
- Analysis of gene targets and therapeutic effects of selected microRNAs.
Main Results:
- Several human microRNAs potently induce cardiomyocyte proliferation.
- miR-17-92, miR-302-367, miR-199a, miR-1825, miR-590, and miR-33b are effective.
- These microRNAs demonstrate potential for therapeutic cardiac regeneration.
Conclusions:
- MicroRNAs represent a promising avenue for treating MI and heart failure.
- Targeted microRNA therapy could enhance cardiac repair mechanisms.
- Further research is warranted for clinical translation of microRNA-based strategies.
